Natco Pharma's marketing partner gets USFDA nod for cancer treatment drug

​​ "Breckenridge Pharmaceutical Inc. has received final approval for its abbreviated new drug application (ANDA) for Pomalidomide Capsules from the US Food and Drug Administration (USFDA)," Natco Pharma said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/35nI6jI
via IFTTT